Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies (2018)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; SHINJO, SUELI MIEKO OBA - FM
- Unidade: FM
- DOI: 10.1186/s42358-018-0030-z
- Subjects: MIOSITE; ANTICORPOS MONOCLONAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Advances in rheumatology
- ISSN: 2523-3106
- Volume/Número/Paginação/Ano: v. 58, article ID 31, 6p, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SOUZA, Fernando Henrique Carlos de et al. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0030-z. Acesso em: 28 mar. 2024. -
APA
Souza, F. H. C. de, Miossi, R., Moraes, J. C. B. de, Bonfá, E. S. D. de O., & Shinjo, S. K. (2018). Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, 58. doi:10.1186/s42358-018-0030-z -
NLM
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 mar. 28 ] Available from: https://doi.org/10.1186/s42358-018-0030-z -
Vancouver
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 mar. 28 ] Available from: https://doi.org/10.1186/s42358-018-0030-z - Alta prevalência de tabagismo em pacientes com artrite reumatóide de início precoce
- Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity
- Lysyloxidase related genes identification by siRNA knockdown
- Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
- Endothelial function features and properties of large vessel behavior in systemic autoimmune diseases: a cross-talk among cardiovascular disease risk factors
- Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies
- Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis
- Eficácia do micofenolato mofetil na nefrite lúpica membranosa
- Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
- The frequency of high/moderate lipoprotein risk factor for coronary artery disease is sifnificant in juvenile-onset systemic lupus erythematosus
Informações sobre o DOI: 10.1186/s42358-018-0030-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas